Neurosurgery notes/Tumours/Gliomas, Glioneuronal Tumors, and Neuronal Tumors/Glioneuronal and neuronal tumours/Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC)

Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC)

View Details
Status
Done

Definition

  • Essential:
    • Methylation profile of DGONC AND
    • Nuclear clusters of small to medium-sized cells exhibiting oligodendroglioma-like morphology AND
    • Strong expression of both OLIG2 and synaptophysin AND
    • Absence of widespread GFAP expression
  • Desirable:
    • Monosomy of chromosome 14
  • Caveat:
    • DNA methylation profiling is so far the only method to clearly identify DGONC.
    • If DNA methylation profiling is not available, morphological features may provide an approximation.

General

  • 1st described in 2020 by Deng et al
  • Methylation defined tumour type

Numbers

  • Mainly paediatric
    • A median age of 9 years (range 1–75 years)

Location

  • Supratentorial
    • Temporal lobe (11/21 cases).

Clinical features

  • Not specific but depends on location of tumour in the brain

Pathology

  • Lack of

Immunophenotype

  • Diffusely OLIG2-positive in most cases
  • GFAP-negative.

Origin

  • Because the morphological and immunohistochemical features of DGONC are similar to those of CNS neuroblastoma, it is possible that DGONC represents a type or subtype of a CNS embryonal tumour. Larger series are needed for a definite classification

Genetics

  • Monosomy 14

Radiological

  • CT
    • Internal calcification
  • MRI
      • Well-defined cortical or subcortical supratentorial masses
      • Hyperintense on T2w/FLAIR
      • Little or no contrast enhancement
      • Low ADC values centrally
      • An 11-year old boy presented with seizure.
        • A mass in the right medial frontal lobe shows heterogeneous hyperintensity on T2w (A) and FLAIR (B).
        • Small cysts are noted.
        • Diffusion shows heterogenous signal but a small focus of low ADC (C).
        • The tumour shows small foci of enhancement on T1w-CE (D)
      notion image

Prognosis

  • The 5-year survival rate: 89%